Affiliation: | (1) Department of Neuropharmacology, Max-Planck-Institut für Psychiatrie, Kraepelinstrasse 2, D-8000 München 40, (Federal Republic of Germany);(2) Pharmaceutical Research Department, F. Hoffmann-La Roche & Co. Ltd, CH-4002 Basle, (Switzerland) |